Incyte (INCY) Competitor Comparison
We are evaluating the key criteria listed to compare Incyte (INCY) against its competitors in the Biotechnology industry.
Market Capitalization
10 / 368Gross Profits
8 / 278Total Revenue
5 / 300EBITDA
6 / 337Free Cashflow
4 / 352Quick Ratio
238 / 357Earnings per Share
37 / 359Dividend yield
0 / 6Total Cash
4 / 358Performance 3 years
87 / 368Performance 5 years
142 / 368Performance 10 years
105 / 368Linearity 3 years
8 / 368Linearity 5 years
57 / 368Linearity 10 years
3 / 368Total Rank
9 / 368Dividend Rank
160 / 368Valuation Rank
73 / 368Piotroski Rank
79 / 368Muliplier Rank
78 / 368Total Cash - INCY ranking 4 / 358
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.